July 1, 2021
Former Deputy Director of Diagnostics, Bill and Melinda Gates Foundation, Joins NDA Partners as Expert Consultant
NDA Partners President Earle Martin announced today that Cristina Giachetti, PhD, former Deputy Director of Diagnostics at the Bill and Melinda Gates Foundation, has joined the firm as an Expert...
June 2, 2021
New Manufacturing and Import License Expands Batch Certification Services
ProPharma Group announced that its wholly-owned subsidiary ProPharma Group The Netherlands B.V., has obtained an authorization for a manufacturing and import (MIA) license. Following successful...
May 27, 2021
ProPharma Group and The Planet Group Announce Agreement to Merge
ProPharma Group and The Planet Group have reached a definitive agreement to merge the two companies. ProPharma Group, a portfolio company of Odyssey Investment Partners, is the leading global...
March 2, 2021
ProPharma Group Announces the Acquisition of Diamond Pharma Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...
December 15, 2020
Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...
September 22, 2020
Odyssey Investment Partners To Acquire ProPharma Group
Odyssey Investment Partners To Acquire ProPharma Group: Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire ProPharma Group (or the "Company")...